Donepezil: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 21: | Line 21: | ||
! [[Rivastigmine]] | ! [[Rivastigmine]] | ||
! [[Galantamine]] | ! [[Galantamine]] | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr) | ! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr) | ||
| Line 28: | Line 27: | ||
! .3 | ! .3 | ||
! 1.2 | ! 1.2 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Cmax|C<sub>max</sub>]] (ng/ml) | ! [[Pharmaceutical_Drugs#Cmax|C<sub>max</sub>]] (ng/ml) | ||
| Line 35: | Line 33: | ||
! 29.3 | ! 29.3 | ||
! 42.6 | ! 42.6 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%) | ! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%) | ||
| Line 42: | Line 39: | ||
! 36 | ! 36 | ||
! 100 | ! 100 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%) | ! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%) | ||
| Line 49: | Line 45: | ||
! 40 | ! 40 | ||
! 10 | ! 10 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr) | ! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr) | ||
| Line 56: | Line 51: | ||
! 5 | ! 5 | ||
! 7.3 | ! 7.3 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ||
| Line 63: | Line 57: | ||
! 191 | ! 191 | ||
! 427 | ! 427 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) | ||
! | ! 6.7 (Rat) | ||
! 450 | ! 450 (Human) | ||
! 181390 | ! 181390 (Rat) | ||
! 1995 | ! 1995 (Rat) | ||
|- | |- | ||
! Dosage (mg) | ! Dosage (mg) | ||
| Line 77: | Line 69: | ||
! 6 | ! 6 | ||
! 8 | ! 8 | ||
|- | |- | ||
! Metabolism | ! Metabolism | ||
! Hepatic (CYP2D6 & CYP3A4) | ! Hepatic (CYP2D6 & CYP3A4) | ||
! | ! Hepatic (CYP1A2) | ||
! | ! Cholinesterase | ||
! | ! Hepatic (CYP3A4 & CYP2D6) & Cholinesterase | ||
|} | |} | ||